The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders
Industry PharmaceuticalsMajor
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GBPIX | 10.56 | N/A | N/A |
Meeder Global Allocation Institutional | |||
KLCKX | 19.32 | N/A | N/A |
Federated Hermes Kaufmann Large Cap R | |||
SBLYX | 57.58 | -0.01 | -0.02% |
ClearBridge Large Cap Growth I | |||
NFALX | 22.78 | -0.02 | -0.09% |
Neuberger Berman Focus I | |||
LCMGX | 14.73 | -0.11 | -0.74% |
Lord Abbett Micro Cap Growth C |
A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AZN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AZN could also see price increases.
Ticker / NAME | Correlation To BIIB | 1D Price Change % | ||
---|---|---|---|---|
BIIB | 100% | -0.48% | ||
AZN - BIIB | 34% Loosely correlated | +1.21% | ||
JNJ - BIIB | 32% Poorly correlated | -0.72% | ||
MRK - BIIB | 29% Poorly correlated | -0.37% | ||
PFE - BIIB | 29% Poorly correlated | -0.49% | ||
ABBV - BIIB | 27% Poorly correlated | -0.45% | ||
More |
Ticker / NAME | Correlation To BIIB | 1D Price Change % |
---|---|---|
BIIB | 100% | -0.48% |
autoimmune (undefined stocks) | 99% Closely correlated | -3.30% |
neurological (undefined stocks) | 76% Closely correlated | +0.07% |
therapy (undefined stocks) | 67% Closely correlated | -0.81% |
challenging disorders (undefined stocks) | 64% Loosely correlated | -1.94% |
Pharmaceuticals: Major (undefined stocks) | 40% Loosely correlated | -0.13% |
More |